Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer

Clinical trial NCT00466752 · COMPLETED

Trial details

NCT number: NCT00466752
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Stage II Prostate Cancer Stage III Prostate Cancer

Start date: 2006-12-01
Primary completion: 2010-04-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.